🔗 Visit the ClinicalTrials.gov page for NCT02765802
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. | Nat Immunol | 2002 | 11.87 |
| 2 | IL-28, IL-29 and their class II cytokine receptor IL-28R. | Nat Immunol | 2002 | 11.22 |
| 3 | Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. | Nat Rev Gastroenterol Hepatol | 2010 | 1.56 |